The Daily Dig
Resilience and Eli Lilly are expanding their manufacturing partnership with a $750 million investment to increase U.S. production of Lilly's KwikPen injectable device. The device is used to deliver diabetes and obesity medicines. The expansion builds on a partnership the two companies first established in 2023 and has expanded Resilience's existing manufacturing operations in the Cincinnati region.
Site preparation is underway, with full operations targeted for early 2027.
The investment is expected to bring total Resilience-created jobs in Ohio to more than 1,400 across its facilities, with at least 400 tied directly to this expansion. Resilience currently runs two advanced facilities in the Cincinnati region totaling nearly 1 million square feet, employing close to 1,000 people across manufacturing, operations, quality, and regulatory roles.
The expansion follows Resilience's recent move of its global headquarters from California to Blue Ash, Ohio. It also deepens a partnership that has already produced more than 150 million doses of Lilly medicines for U.S. patients in vial and pre-filled syringe formats.
Snapshot:
Companies Involved: Resilience, Eli Lilly and Company
Investment Value: $750 million
Project Type: Pharmaceutical manufacturing expansion
Product Focus: KwikPen injectable device (diabetes and obesity medicines)
Region: Cincinnati, Ohio region
Jobs Tied to Expansion: At least 400 high-skilled positions (included within the 1,400 total below)
Total Resilience-Created Jobs in Ohio: More than 1,400 across its facilities
Existing Resilience Footprint (Cincinnati region): Nearly 1 million sq. ft. across two facilities
Existing Resilience Workforce (Cincinnati region): Nearly 1,000 employees
Status: Site preparation underway
Timeline: Full operations targeted for early 2027
Partnership Origin: Established in 2023
Company Headquarters: Recently relocated to Blue Ash, Ohio
Economic and Workforce Development Partners: JobsOhio, REDI Cincinnati, Ohio Life Sciences (OLS)
TheJobWalk Thoughts
Full operations are targeted for early 2027, but the release doesn't detail how much construction remains. The $750 million investment has already "expanded" Resilience's operations, so some of the work may be underway rather than starting from scratch.
The headquarters move to Blue Ash and this expansion together point to real staying power in Ohio, not a one-off announcement. That's a company worth tracking for future opportunities in the state.
JobsOhio, REDI Cincinnati, and Ohio Life Sciences are named as partners building a manufacturing talent pipeline in Ohio. That pipeline targets production careers, not construction trades, so it says nothing about labor availability for the build itself.
Source: BusinessWire
